SNK01 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Phase 1/2 · Moderate Alzheimer Disease |
NKGen Biotech, Inc. | SNK01 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|